Have a feature idea you'd love to see implemented?
Let us know!
AXGN Axogen Inc
Price (delayed)
$13.125
Market cap
$577.61M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.32
Enterprise value
$624.25M
Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore
Highlights
The company's EPS rose by 43% YoY and by 16% QoQ
Axogen's net income has increased by 38% YoY and by 13% QoQ
Axogen's gross margin has decreased by 2.9% YoY
Key stats
What are the main financial stats of AXGN
Market
Valuations
Earnings
Shares outstanding
44.01M
Market cap
$577.61M
Enterprise value
$624.25M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.79
Price to sales (P/S)
3.18
EV/EBIT
N/A
EV/EBITDA
364
EV/Sales
3.45
Revenue
$180.86M
EBIT
-$6.06M
EBITDA
$1.72M
Free cash flow
-$8.31M
Per share
Balance sheet
Liquidity
EPS
-$0.32
Free cash flow per share
-$0.19
Book value per share
$2.27
Revenue per share
$4.12
TBVPS
$4.26
Total assets
$191.99M
Total liabilities
$92.58M
Debt
$71.31M
Equity
$99.41M
Working capital
$63.22M
Debt to equity
0.72
Current ratio
3.74
Quick ratio
2.39
Net debt/EBITDA
27.2
Margins
Efficiency
Dividend
EBITDA margin
0.9%
Gross margin
76.4%
Net margin
-7.9%
Operating margin
-4.7%
Return on assets
-7.5%
Return on equity
-14.9%
Return on invested capital
-2.9%
Return on capital employed
-3.6%
Return on sales
-3.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AXGN stock price
How has the Axogen stock price performed over time
Intraday
1.74%
1 week
5.25%
1 month
-0.19%
1 year
120.22%
YTD
92.17%
QTD
-6.38%
Financial performance
How have Axogen's revenue and profit performed over time
Revenue
$180.86M
Gross profit
$138.17M
Operating income
-$8.5M
Net income
-$14.31M
Gross margin
76.4%
Net margin
-7.9%
AXGN's operating margin has soared by 70% YoY and by 33% QoQ
Axogen's operating income has soared by 64% YoY and by 30% from the previous quarter
The company's net margin rose by 48% YoY and by 17% QoQ
Axogen's net income has increased by 38% YoY and by 13% QoQ
Growth
What is Axogen's growth rate over time
Valuation
What is Axogen stock price valuation
P/E
N/A
P/B
5.79
P/S
3.18
EV/EBIT
N/A
EV/EBITDA
364
EV/Sales
3.45
The company's EPS rose by 43% YoY and by 16% QoQ
AXGN's P/B is 39% above its last 4 quarters average of 4.1 and 29% above its 5-year quarterly average of 4.4
The equity has increased by 3.9% QoQ
AXGN's P/S is 36% above its last 4 quarters average of 2.3 but 15% below its 5-year quarterly average of 3.7
The revenue has grown by 19% YoY and by 4.2% from the previous quarter
Efficiency
How efficient is Axogen business performance
The company's return on sales has surged by 77% YoY and by 37% QoQ
Axogen's return on invested capital has surged by 73% YoY and by 37% QoQ
The ROA has increased by 38% YoY and by 13% from the previous quarter
Axogen's ROE has increased by 37% YoY and by 14% from the previous quarter
Dividends
What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AXGN.
Financial health
How did Axogen financials performed over time
The total assets is 107% higher than the total liabilities
AXGN's current ratio is up by 14% year-on-year and by 7% since the previous quarter
Axogen's quick ratio has increased by 7% from the previous quarter and by 3% YoY
The company's debt is 28% lower than its equity
The equity has increased by 3.9% QoQ
The debt to equity has contracted by 4% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.